Clinical Trial Update: Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas [Phase 2]

View source ↗

Summary

A Phase 2 platform study evaluating neoadjuvant and adjuvant immunotherapy for patients with resectable pancreatic adenocarcinoma; the trial is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING